Verdezyne is a privately held industrial biotechnology company that is developing and commercializing novel genetically engineered microorganisms for use as “factories” to manufacture renewable chemicals. Verdezyne’s unique microorganisms permit greener, cleaner and more cost effective production of chemicals compared with traditional methods. The Company is commercializing its technology through partnerships with leading chemical manufacturers.
The company’s first commercial is impending. Verdezyne and Bio-XCell Malaysia have reached an agreement to construct Verdezyne’s first commercial-scale renewable chemicals manufacturing facility in Bio-XCell’s premier biotechnology and ecosystem park in Nusajaya, Iskandar, in southern Malaysia. The multi-faceted agreement includes the 13-year, renewable lease of a 6.9-acre site, as well as a loan of approximately $75 million from Bio-XCell.
Construction is expected to commence in 2015, and the plant will be capable of producting up to 30 million pounds per year of diacids, including DDDA, and will be the world’s first bio-based plant for the production of DDDA.